Works about PIPERIDINE

Results: 1847
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinoma.

    Published in:
    Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae143
    By:
    • Arndt, Annette;
    • Neumann, Christian;
    • Riecke, Armin;
    • Bauer, Arthur;
    • Müller, Matthias;
    • Wölfle-Guter, Manuela;
    • Grunert, Michael;
    • Busch, Hauke;
    • Künstner, Axel;
    • Bubnoff, Nikolas von;
    • Fliedner, Stephanie;
    • Greinert, Dina;
    • Osius, Jasmin;
    • Nagarathinam, Kumar;
    • Steinestel, Konrad;
    • Gorantla, Sivahari Prasad;
    • Gebauer, Niklas;
    • Witte, Hanno M
    Publication type:
    Article
    35
    36

    Novel SLC12A2‐ROS1 Fusion in Non‐Small Cell Lung Cancer with a Significant Response to Crizotinib: The Importance of Choosing the Appropriate Next‐Generation Sequencing Assay.

    Published in:
    Oncologist, 2021, v. 26, n. 6, p. e908, doi. 10.1002/onco.13745
    By:
    • Rodríguez‐Antolín, Carlos;
    • Rosas‐Alonso, Rocío;
    • Cruz, Patricia;
    • Higuera, Oliver;
    • Sánchez‐Cabrero, Darío;
    • Esteban‐Rodríguez, Isabel;
    • Peláez‐García, Alberto;
    • Fernández Montaño, Victoria Eugenia;
    • Rodríguez‐Jiménez, Carmen;
    • Ibáñez de Cáceres, Inmaculada;
    • Castro, Javier
    Publication type:
    Article
    37
    38
    39
    40
    41

    A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors.

    Published in:
    Oncologist, 2019, v. 24, n. 9, p. 1151, doi. 10.1634/theoncologist.2018-0749
    By:
    • Michaelson, M. Dror;
    • Gupta, Shilpa;
    • Agarwal, Neeraj;
    • Szmulewitz, Russell;
    • Powles, Thomas;
    • Pili, Roberto;
    • Bruce, Justine Yang;
    • Vaishampayan, Ulka;
    • Larkin, James;
    • Rosbrook, Brad;
    • Wang, Erjian;
    • Murphy, Danielle;
    • Wang, Panpan;
    • Lechuga, Maria Josè;
    • Valota, Olga;
    • Shepard, Dale R.
    Publication type:
    Article
    42
    43

    Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.

    Published in:
    Oncologist, 2017, v. 22, n. 3, p. 255, doi. 10.1634/theoncologist.2016-0279
    By:
    • Vanden Borre, Pierre;
    • Schrock, Alexa B.;
    • Anderson, Peter M.;
    • Morris, John C.;
    • Heilmann, Andreas M.;
    • Holmes, Oliver;
    • Wang, Kai;
    • Johnson, Adrienne;
    • Waguespack, Steven G.;
    • Ou, Sai‐Hong Ignatius;
    • Khan, Saad;
    • Fung, Kar‐Ming;
    • Stephens, Philip J.;
    • Erlich, Rachel L.;
    • Miller, Vincent A.;
    • Ross, Jeffrey S.;
    • Ali, Siraj M.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50